Navigation Links
Larta Institute Partners With Burrill & Company to Present the 14th Annual Life Sciences Venture Forum

SANTA CLARA, Calif., April 10 /PRNewswire/ -- Dedicating this year's Venture Forum to the life sciences industry, Larta Institute and Burrill & Company have announced a partnership in developing and producing the 2008 Life Sciences Venture Forum, which will showcase the most promising and innovative seed and early-stage life sciences companies from the U.S. and around the globe. The 2008 Life Sciences Venture Forum will take place on May 30, 2008, at the Santa Clara Convention Center and will provide venture capitalists, angel investors and industry representatives the opportunity to get a first look at companies that are not seen on the regular conference circuit and cannot be accessed via traditional pipelines.

"This partnership unites the best of the best," said Rohit Shukla, CEO of Larta Institute. "It extends the reach, brand and credibility of Burrill & Company to the world of early-stage innovations and Larta Institute's own focus and access to that pool of talent," he added. "With this partnership, the Venture Forum grows several notches."

G. Steven Burrill, CEO of Burrill & Company, said, "Different areas of discovery are converging in the life sciences. There is no more exciting a time for emerging innovations to fill large holes in the realization of these trends." He added that "the 2008 Life Sciences Venture Forum promises to be an important platform for demonstration and feedback of these innovations, and we are excited to be a part of it."

Now 14 years strong, the Venture Forum is the largest and longest-running showcase of early stage innovation and entrepreneurship. It is the must-attend event for those seeking access to untapped early-stage deal flow from around the world.

Larta Institute's Commercialization Assistance Practice is rooted in a set of year-round programs that uncover, coach and train innovators funded by institutions such as the National Institutes of Health, the US Department of Agriculture and a network of over 25 universities. Larta's practice extends to all corners of the globe, uncovering market-ready innovations spinning out of research institutes and leading R&D centers. Through its dedicated Life Science Practice, Larta Institute works with more than 100 emerging companies every year.

Burrill & Company works exclusively with life sciences companies; through its industry expertise, Burrill & Company gives pioneering companies the tools they need to start strong and maintain growth via venture capital funds, merchant banking and the formation of business development partnerships. Unsurpassed in industry networking, Burrill & Company provides invaluable resources, strategies and years of dedicated experience to promising life sciences companies.

Burrill & Company's specific expertise and breadth of knowledge in life sciences constitute a strong complement to Larta Institute's commercialization assistance practice and industry network. The resources and commitment of both partner organizations will be leveraged to advance the visibility and success of all presenting and exhibiting entrepreneurs at the 2008 Life Sciences Venture Forum.

2008 Life Sciences Venture Forum (May 30, 2008 - Santa Clara Convention Center)

Attendee Registration Registration for the event is $995. Register early to receive a 40% discount. Go to

Credentialed Media: To register for a press pass, please contact Avi Kulokas at or 213-538-1451.

Sponsorship Opportunities For information on sponsorship opportunities contact Carlos Gutierrez at or 213-538-1453.

For more information about Larta Institute, please visit

For more information about Burrill & Company, please visit


Constanza Pachon

Tel.: 213/538-1451


This release was issued through eReleases(TM). For more information, visit

SOURCE Larta Institute
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Loma Linda University Partners With Larta Institute for Technology Marketing Program
2. Immune Tolerance Institute Appoints Aaron B. Kantor Ph.D. Chief Scientific Officer
3. Raven biotechnologies and Bioprocessing Technology Institute Announce Collaboration to Advance Discovery of Stem Cell Antibodies
4. Strategic Diagnostics Inc. Selected as Key Supplier to SAIC-F and the National Cancer Institute for the Development of a Comprehensive Portfolio of Antibodies for Use in Cancer Research
5. Piedmont Heart Institute Welcomes Cardiology of Georgia
6. The Immune Tolerance Institute Announces Collaboration with Beckman Coulter Establishing a Multiplatform Immunophenotyping/Immunogenotyping Laboratory
7. Aida Pharmaceuticals, Inc. Acquires High-Level Research Institute in the Peoples Republic of China
8. Aida Acquires High-Level Research Institute in China
9. Boston Biomedical Research Institute Maintains Baa3 Rating from Moodys
10. WaferGen to Present at the Cambridge Health Institutes Fifth Annual Molecular Diagnostics Partnerships in Personalized Medicine Conference
11. Allen Institute for Brain Science Launches Three New Landmark Atlas Projects Focusing on the Human Brain, Developing Brain and Spinal Cord
Post Your Comments:
(Date:11/25/2015)... CA (PRWEB) , ... November 25, 2015 , ... ... genomics company uBiome, were featured on AngelList early in their initial angel funding ... an AngelList syndicate for individuals looking to make early stage investments in the ...
(Date:11/24/2015)... 2015 /CNW/ - iCo Therapeutics ("iCo" or "the Company") ... for the quarter ended September 30, 2015. Amounts, ... and presented under International Financial Reporting Standards ("IFRS"). ... said Andrew Rae , President & CEO ... not only value enriching for this clinical program, ...
(Date:11/24/2015)... -- --> --> ... Market by Product & Services (Primer, Probe, Custom Oligos, ... End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) - Global ... expected to reach USD 1,918.6 Million by 2020 from ... 10.1% during the forecast period. Browse 183 ...
(Date:11/24/2015)... Ltd. (OTCQB: TIKRF) today announced that its Annual General Meeting of Shareholders ... Israel time, at the law offices of Goldfarb Seligman ... Floor, Tel Aviv, Israel . ... to the Board of Directors; , election of Liat ... an amendment to certain terms of options granted to our Chief Executive ...
Breaking Biology Technology:
(Date:11/17/2015)... Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and ... of broadly enabling, pressure cycling technology ("PCT")-based sample preparation ... it has received gross proceeds of $745,000 from an ... "Offering"), increasing the total amount raised to date in ... are expected in the near future. ...
(Date:11/12/2015)... BOSTON , Nov. 12, 2015  A golden ... for Duchenne muscular dystrophy (DMD) has provided a new ... Boston Children,s Hospital, the Broad Institute of MIT and ... Brazil . Cell, ... some dogs "escape" the disease,s effects. The Boston Children,s ...
(Date:11/12/2015)... 2015   Growing need for low-cost, easy ... been paving the way for use of biochemical ... analytes in clinical, agricultural, environmental, food and defense ... in medical applications, however, their adoption is increasing ... continuous emphasis on improving product quality and growing ...
Breaking Biology News(10 mins):